P

Inventor

NANCHAHAL JAGDEEP

GB9 patents
⚠️ This page may combine multiple inventors who share the name “NANCHAHAL JAGDEEP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

180 THERAPEUTICS LP

3 patents
US12344667B2Jul 1, 2025

Method of treating early stage Dupuytren's disease

180 THERAPEUTICS LP0 citations58
US11613570B2Mar 28, 2023

Method of treating dupuytren's disease using a pre-filled syringe

180 THERAPEUTICS LP0 citations58
US11400154B2Aug 2, 2022

Method of treating a localized fibrotic disorder using an IL-33 antagonist

180 THERAPEUTICS LP0 citations57

UNIV OXFORD INNOVATION LTD

2 patents
US10669334B2Jun 2, 2020

Treatment for Dupuytren's disease

UNIV OXFORD INNOVATION LTD2 citations70
US10273296B2Apr 30, 2019

Treatment for dupuytren's disease

UNIV OXFORD INNOVATION LTD3 citations70

THE KENNEDY TRUST FOR RHEUMATOLOGY RES

2 patents
US11220540B2Jan 11, 2022

Methods for reducing post-operative cognitive dysfunction (POCD)

THE KENNEDY TRUST FOR RHEUMATOLOGY RES2 citations63
US12325744B2Jun 10, 2025

Methods for reducing post-operative cognitive dysfunction (POCD)

THE KENNEDY TRUST FOR RHEUMATOLOGY RES0 citations54

NANCHAHAL JAGDEEP

1 patent
US9138458B2Sep 22, 2015

Treatment for dupuytren's disease

NANCHAHAL JAGDEEP6 citations77

LARSEN GLENN

1 patent
US10500273B2Dec 10, 2019

Method of treating a localized fibrotic disorder using an IL-33 antagonist

LARSEN GLENN1 citations53